Orexo AB (publ)


14.5 (SEK) • At close February 20, 2024
Bedrijfsnaam Orexo AB (publ)
Symbool ORX.ST
Munteenheid SEK
Prijs 14.5
Beurswaarde 498,329,867
Dividendpercentage 0%
52-weken bereik 8.44 - 20.1
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Nikolaj Sorensen
Website https://www.orexo.com

An error occurred while fetching data.

Over Orexo AB (publ)

Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, Europe, and the United Kingdom. Its products include Zubsolv tablets for the treatment of opioid dependence; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of

Vergelijkbare Aandelen

Physitrack PLC logo

Physitrack PLC


15.2 SEK

Integrum AB (publ) logo

Integrum AB (publ)


43.35 SEK

SpectraCure AB (publ) logo

SpectraCure AB (publ)


2.605 SEK

Infant Bacterial Therapeutics AB (publ) logo

Infant Bacterial Therapeutics AB (publ)


93.4 SEK

Boule Diagnostics AB (publ) logo

Boule Diagnostics AB (publ)


9.36 SEK

Karolinska Development AB (publ) logo

Karolinska Development AB (publ)


1.65 SEK

Enzymatica AB (publ) logo

Enzymatica AB (publ)


3.05 SEK

Egetis Therapeutics AB (publ) logo

Egetis Therapeutics AB (publ)


6.07 SEK

Financiële Gegevens

Cijfers zijn in miljoenen (SEK)

Cijfers zijn in miljoenen (SEK)